Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVO756 in Adults With Atopic Dermatitis
NCT07150845Phase 2Completed
- Sponsor
- Evommune
- Start
- Aug 2025
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of EVO756 in atopic dermatitis (AD), sponsored by Evommune. Started Aug 2025; status: completed.
02
Drugs
EVO756
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07150845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07150845.